Dramatic advance in the technology to fight global warming

Carbon nanotubes grown by C2CNT directly from carbon dioxide (SEM and TEM imaging). Right. The carbon nanotube wall showing the cylindrical layers of graphene comprised of individual carbons. (credit, S. Licht, C2CNT)

Massive elimination of the greenhouse gas carbon dioxide through CNT-cement and CNT-aluminum. (credit, S. Licht, C2CNT)

C2CNT process is a new, high yield chemistry that splits the greenhouse gas CO2 into carbon nanotubes and oxygen, and photograph at C2CNT’s Carbon Xprize Plant for the direct conversion of CO2 directly from the flue gas of the Shepard. (credit, S. Licht, C2CNT)

Our ‘Diamonds from the sky’ technology transforms anthropogenic CO2 into valuable carbon nanomaterials and composites to mitigate greenhouse gases and pioneer a carbon economy to stop global warming.”

— Stuart Licht

CALGARY , ALBERTA, CANADA, August 30, 2019 /EINPresswire.com/ — A study released today in Materials Today Sustainability provides a several hundred-fold advance in stopping the release of the greenhouse gas carbon dioxide. This advance provides a path to not only slow the rate CO2 rises, but actually decrease the level of that greenhouse gas in the atmosphere. C2CNT refers to CO2 to carbon nanotubes. The study, “Amplified CO2 reduction of greenhouse gas emissions with C2CNT carbon nanotube-composites”, authored by C2CNT founder Dr. Stuart Licht and the C2CNT team, outlines the C2CNT process and its utilization of CO2 to produce carbon nanotubes (CNTs). Carbon nanotubes or CNTs are the strongest material ever measured. The addition of CNTs to structural materials greatly increases their strength and decimates their carbon footprint.  For example, as reported in the study 1 ton of CNT stops emission of over 800 tons of CO2 as a CNT-cement composite.

One ton of CNT can also avoid:
1. ·      4400 tons of CO2 in aluminum production,
2. ·      2750 tons of CO2 in titanium production,
3. ·      1800 tons of CO2 in magnesium production, or
4. ·      300 tons of CO2 in steel production. 

In this discovery of the C2CNT-composite process, carbon nanotubes are produced by a process called electrolysis at low cost. Then the CNTs are mixed with the structural material. In addition to the CO2 reduction using the CNT-composites, a further reduction occurs from the 4 tons of CO2 consumed in making the CNTs (CO2 is the only material consumed to produce the CNTs and the only two products are pure carbon CNTs and oxygen). C2CNT is a Finalist competing in the Carbon XPRIZE competition (www.CarbonXprize.org, www.C2CNT.com). As part of the XPRIZE competition, C2CNT is testing their technology with natural gas power plant flue gas at demonstration scale at the Alberta Carbon Conversion Technology Centre located in Calgary, Canada.   

The new C2CNT-composite process would allow for example the entire greenhouse gas emission of a fossil fuel power plant to be offset with a small, onsite C2CNT plant producing carbon nanotubes. C2CNT has previously demonstrated the production of carbon nanotubes not only from flue gas, but also directly from the air (direct air carbon capture without any need to first concentrate the CO2), and determined that an area equal to 4% of the Sahara Desert is sufficient to terraform the CO2 concentration (engineer the atmosphere) back to pre-industrial levels in ten years.

Massive consumption and removal of CO2 can minimize the species extinction, disruption to the global economy, climate change hurricanes, floods and droughts and prevent global warming from changing life as we know it.  C2CNT is on path to a nanocarbon based economy aimed at changes comparable to the introduction of the plastics economy. The nanocarbon economy consumes CO2 and improves common products, such as more powerful batteries, taller buildings, stronger bridges, lighter vehicles and airplanes, bullet & shock proof thin clothing and through carbon nanomaterials made from CO2. 

The study is at:
Materials Today Sustainability: “Amplified CO2 reduction of greenhouse gas emissions with C2CNT carbon nanotube-composites” by Licht, Liu, Licht, Wang, Swesi and Chan, available at: 
https://doi.org/10.1016/j.mtsust.2019.100023

Further details are in the galley proofs available by email request to info@C2CNT.com

Read more at:
Journal of CO2 Utilization: “Exploration of alkali cation variation on the synthesis of carbon nanotubes by electrolysis of CO2 in molten carbonates” by Wang, Liu, Licht, Wang, and Licht, available at: https://doi.org/10.1016/j.jcou.2019.07.007

Advanced Sustainable Systems: “Carbon Nano‐Onions Made Directly from CO2 by Molten Electrolysis for Greenhouse Gas Mitigation” by Liu, Ren, Licht, Wang and Licht, available at:
https://doi.org/10.1002/adsu.201900056

Materials Today Energy: “Carbon nanotube wools made directly from CO2 by molten electrolysis: Value driven pathways to carbon dioxide greenhouse gas mitigation” by Johnson, Ren, Lefler, Licht, Vicini, Liu and Licht, available at: 
http://dx.doi.org/10.1016/j.mtener.2017.07.003

Contact:
Stuart Licht
Founder, C2CNT Corp. (www.C2CNT.com)
Professor of Chemistry, George Washington University, Former Program Director US National Science Foundation
Email: info@C2CNT.com

Stuart Licht
C2CNT
+1 857-222-4327
email us here


Source: EIN Presswire

SidePak™ Personal Aerosol Monitor AM520i Named 2019 Product of the Year

OH&S and an independent panel of judges recognized the SidePak AM520i as the 2019 Product of the Year for Confined Space Safety.

SHOREVIEW, MN, UNITED STATES, August 30, 2019 /EINPresswire.com/ — TSI is excited to announce the SidePak™ Personal Aerosol Monitor AM520i won a Product of the Year honor from Occupational Health & Safety magazine. OH&S and an independent panel of judges recognized the SidePak AM520i as the 2019 Product of the Year for Confined Space Safety. The award program honors health and safety manufacturers whose new products are considered particularly noteworthy in their ability to improve workplace safety.

TSI's SidePak AM520i is the smallest and lightest real-time personal exposure monitor on the global market certified for intrinsically safe design in confined spaces, underground mines, and volatile or potentially explosive environments. The instrument combines real-time dust monitoring with IECEx/ATEX/CSA and now SIMTARS certifications for use in environments around the world requiring intrinsically safe instruments.

"The AM520i is a game-changer for many of our customers who have had few options for a small personal dust monitor with the level of intrinsically safe certifications this product has achieved," said Kevin Chase, TSI Global Product Manager for Health & Safety. "Confined space is a key application for monitoring respirable dust where intrinsically safe instruments are required. We are grateful for this recognition and proud to offer a real-time respirable particle exposure monitor that helps protects workers on the job in challenging and volatile environments."

OH&S plans to recognize 2019 Product of the Year winners in their November/December issue of Occupational Health & Safety magazine. To see 2019's Product of the Year winners in all categories, visit the OH&S 2019 New Product of the Year Award page online. All eligible products made their debut to the market between July 2018, and July 2019.

About TSI Incorporated
TSI Incorporated serves a global market by investigating, identifying, and solving measurement problems. As an industry leader in the design and production of precision instruments, TSI partners with research institutions and customers around the world.

Polly Jennings
TSI
+1 651-490-2741
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Gary Alter, Acclaimed Plastic Surgeon, Travels to Chile for Reconstructive Surgery Congress

Dr. Gary Alter, Acclaimed Plastic Surgeon

Dr. Alter recently travelled to Chile to be a guess faculty speaker at the 2019 Chilean Plastic and Reconstructive Surgery Congress in Santiago, Chile.

LOS ANGELES, CA, UNITED STATES, August 30, 2019 /EINPresswire.com/ — Dr. Gary Alter, acclaimed plastic surgeon, has had an incredibly busy year so far. Between teaming up with the Stem Cell Doctors of Beverly Hills to open his new state-of-the-art Biocellular Center, (https://stemcelldoctorsbeverlyhills.com/), he also recently travelled to Chile to be a guess faculty speaker at the 2019 Chilean Plastic and Reconstructive Surgery Congress in Santiago, Chile, which took place August 8-10, 2019.

“It was an amazing experience,” explains Dr. Alter, “I spoke on topics such as ‘buried penis’, ‘female genital aesthetic surgery including reconstruction of botched labiaplasties,’ ‘male to female gender confirmation surgery,’ ‘reconstruction of deformities from penile enlargement surgery,’ and ‘scrotum reduction.’” "The plastic surgeons were very gracious and interested in my work."

Dr. Gary Alter is an American plastic surgeon. His specialties include male and female genital reconstruction and gender confirmation surgery. He appeared in multiple episodes of the reality television series, "Dr. 90210" and one episode of “Botched”, both on the E! television network. He currently has an acclaimed practice in Beverly Hills, CA and Manhattan, NY.

Dr. Alter was the second surgeon ever with board certification by both the American Board of Plastic Surgery and the American Board of Urology. He is an Assistant Clinical Professor of Plastic Surgery at UCLA School of Medicine. Dr. Alter performs most cosmetic plastic surgical procedures, but his sub-specialty is in genital aesthetic and reconstructive surgery. He has invented many original surgical procedures adopted by other surgeons worldwide, including the "Alter Central Wedge labiaplasty technique".

The acclaimed doctor has been highlighted on Alexis Arquette: She's My Brother (documentary) and on the TLC show Strange Sex, discussing hidden penis syndrome. He has appeared on the Discovery Health Network, TLC, CNN, the Larry King Show, and was a recurrent guest on "Red Eye" on the Fox News Channel. He has also been featured in numerous media outlets including the New York Times, the Los Angeles Times, the Wall Street Journal, USA Today, Allure, Self, Glamour, Marie Claire, Cosmopolitan, and Health.

“My trip to Chile was an enriching experience,” concludes Dr. Alter, “I will continue traveling and speaking worldwide to share my knowledge about my unique procedures.”

Aurora DeRose
Michael Levine Media
+1 310-396-6090
email us here


Source: EIN Presswire

Mike Page, Alexion Pharmaceuticals invite to SMi's Orphan Drugs & Rare Diseases Conference

SMi Reports: Mike Page, Executive Director at Alexion Pharmaceuticals invites heads of medical affairs and all interested to SMi’s Orphan Drugs & Rare Diseases

LONDON, GREATER LONDON, UNITED KINGDOM, August 30, 2019 /EINPresswire.com/ — Mike Page will be co-chairing the conference with Rick Thompson, CEO at Findacure, which will be taking place on 15th and 16th October in London.

This conference will bring together a broad spectrum of experts from across the orphan drug world. The two-day compact agenda will offer a series of presentations, through which you will gain key insights into current trends and innovations in orphan drug development, using real world case studies to illustrate challenges and opportunities.

The rare and ultra rare disease landscape is constantly changing as new diagnostic and therapeutic technologies emerge and partnerships are developed to address patient access and funding issues. At the conference, speakers from patient organisations, pharmaceutical R&D companies, health technology assessment groups, and others will lay out the current landscape and address how the orphan drug space will develop as the century continues.

Delegates will gain many invaluable insights from this event, on major topics such as:
• International perspectives on state-of-the-art rare disease research and development
• Patient perspectives on the challenges of navigating the path to diagnosis and encouraging research interest in rare diseases
• Cutting edge innovations with emerging technologies including stem cell therapy and artificial intelligence
• Appraisal of real-world value for new therapies in the orphan drug arena
• Following the conference there will be a half day workshop where delegates will deep dive into strategies for accelerating patient access to orphan drugs, addressing issues, opportunities and barriers, that are met when developing a product for patients with rare diseases.

To view the full details of the 2-day conference agenda, half-day workshop and the expert speaker line-up, please view the brochure available to download online http://www.orphandrugs.co.uk/pr4

For sponsorship and exhibitor enquiries, please contact Alia Malick on on +44 (0) 207 827 6168 or amalick@smi-online.co.uk

SMi’s 9th Annual Orphan Drugs and Rare Diseases 2019
Conference: 15th – 16th October 2019
Workshop: 17th October 2019
London, UK
http://www.orphandrugs.co.uk/pr4
#SMiOrphanDrugs

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
7800890224
email us here


Source: EIN Presswire

Global Q-TOF Mass Spectrometry Market to Reach 1000 Million USD by 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Global Q-TOF Mass Spectrometry Market to Reach 1000 Million USD by 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Q-TOF Mass Spectrometry Industry 2019

Description:-

Mass Spectrometry is a technique used to measure the mass-to-charge ratio of ions. Invented by Nobel laureate Wolfgang Paul, Quadrupole-Time of Flight or Q-TOF Mass Spectrometry is a type of mass spectrometry where the mass-to-charge ratio of an ion is measured using a time of flight measurement, in which the ions are speeded up by an electric field of pre-determined strength, and the results are displayed as a mass spectrum.

This technique has its uses in several fields such as biochemistry, pharmacokinetics, food safety, drug testing and space exploration to name a few.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3689411-global-q-tof-mass-spectrometry-market-2018-by

For more information or any query mail at sales@wiseguyreports.com

The global Q-TOF Mass Spectrometry market was valued at 700 million USD in 2017 and is expected to reach 1009.7 million USD by the end of 2022, growing at a CAGR of 7.7% between 2017 and 2023.

This report analyzes the status and worldwide scope of the Q-TOF Mass Spectrometry market during the period 2017-2023, outlines the key players, and splits the market by the types of this technique and its applications.

Segmentation:

The key players in the Q-TOF Mass Spectrometry market across the world include the following:
Agilent Technologies
Bruker
Shimadzu Corporation
Waters Corporation
Danaher

Based on the type, this market can be divided into two broad categories, namely Two-Grade and Three-Grade, whereas, based on application, the Q-TOF Mass Spectrometry market is split up across industries such as biotechnology, food and beverage testing, pharmaceuticals, petrochemicals and environmental testing. The growing applications of this technique in these sectors, positive government initiatives, and a larger focus on the production of high-quality products has ensured a steady market growth for this technology, especially in growing economies such as Latin America and the Asia Pacific region.

Regional Analysis:
Based on historical data, market experts predict that the Asia Pacific region will occupy a higher market share in the future forecasted period, with China being a major market, followed by India and South East Asia. However, in terms of market growth, it may be noted that North America will be the market leader, particularly the United States, as any significant change from the US would impact the development of Q-TOF Mass Spectrometry in other markets. Besides, the growth in government funding and increasing research in the biotechnology and pharmaceutical fields in the US are also major drivers for growth of the North American as well as Canadian market. Europe is also estimated to play an important role in the global market.

Industry News:
According to the latest news, the application of the Q-TOF Mass Spectrometry technique will see the highest growth in the field of biotechnology, with biotechnology expected to register the highest CAGR during the forecast period. The downside of this technology is the high costs of the Q-TOF instruments, which are hampering the growth of this market to a certain extent. However, with the United States and Canada getting substantial government grants for research and development, this market is expected to provide ample opportunities for new players.
Complete Report Details @ https://www.wiseguyreports.com/reports/3689411-global-q-tof-mass-spectrometry-market-2018-by

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Rising instances of IBS to cause growth in global irritable bowel syndrome treatment market 2023

WiseGuyReports.Com Publish a New Market Research Report On –“Rising instances of IBS to cause growth in global irritable bowel syndrome treatment market 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Irritable Bowel Syndrome Treatment Industry 2019

Description:-

In today’s times, irritable bowel syndrome commonly known as IBS is a global issue. IBS occurs because of functional gastrointestinal disorders. Around 15% of the total world population is experiencing symptoms related to IBS. The ones who are suffering the most are women and people below the age group of 50. This problem is caused when there is an imbalance in the way the brain, nervous system, and gut interact with each other. This cause changes in bowel sensation and movement. The most common symptoms of IBS are stomach pain and distress with altered bowel habits. The global irritable bowel syndrome treatment market is expected to grow in the years to come because of the growing anxiety levels of the people, the prevalence of depression, and strong drug pipeline.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3977552-global-irritable-bowel-syndrome-treatment-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

Key Players

Abbott, Allergan Inc., Ardelyx, Inc., Astellas Pharma, Inc., Ironwood Pharmaceuticals, Lexicon Pharmaceuticals, Inc., Mallinckrodt, Nestle Health Science, Synergy Pharmaceuticals Inc., and Valeant Pharmaceuticals International, Inc.
As per the report found on Wise Guy Report (WSR), the global irritable bowel syndrome treatment market is expected to reach a market value of $2,988.6 million by the end of 2023. The market is expected to register a CAGR of 7.58% during the forecast period. The market is driven by the rising prevalence of the target disease along with the increasing uptake of drugs for the same. Also, the rising commercialization of the drugs will accelerate the growth in the forecast period.

Various pharmaceutical companies are working on some promising products which are currently under clinical trials. These products will address the unmet needs of people in this therapy area, which will further accelerate the growth.

Segmentation:
The global irritable bowel syndrome treatment market is segmented based on type, drug type, and end user. Such insights allow the market players to develop strategies and develop medicines for the treatment of this global problem.

Based on the type, the global irritable bowel syndrome treatment market is classified into IBS-D, IBS-C, and IBS-M. The largest market share at a CAGR of 8.31% is claimed by IBS-D.
Based on the drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximlin, alosetron, and others. The linaclotide segment accounted for the largest market share at a CAGR of 7.95%.

Based on the end user, the global irritable bowel syndrome treatment market is segmented into hospitals, research laboratories, clinics, and others. The largest market share is taken by hospitals at a CAGR of 8.04%.

Regional Analysis:
America (both North and South), Asia Pacific, Europe, and the Middle East & Africa are considered as the key regions as per the regional analysis of the global irritable bowel syndrome treatment market.
As per the data of the previous years, the United States held the highest share of the global irritable bowel syndrome treatment market followed by Europe and then the Asia Pacific region. By 2023, America is expected to grow at a CAGR of 8.69%.

Industry News:
In 2019, Linzess was approved in China. This is expected to give the global irritable bowel syndrome treatment market a boost. Japan noticed significant growth because of Linzess.

Complete Report Details @ https://www.wiseguyreports.com/reports/3977552-global-irritable-bowel-syndrome-treatment-market-research-report-forecast-to-2023

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Ebstein’s Anomaly 2019 Global Market Outlook,Research,Trends and Forecast to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Ebstein’s Anomaly 2019 Global Market Outlook,Research,Trends and Forecast to 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Ebstein’s Anomaly Industry 2019

Description:-

A rare congenital disease, Ebstein's anomaly occurs due to improper development of the tricuspid valve in the first eight weeks of foetal growth. A disorder that occurs when the tricuspid valve that divides the two chambers of the right side of the heart does not form correctly. Driven by an increasing number of congenital heart diseases and rising population, Ebstein’s Anomaly is also caused by factors such as genetics and the environment. Technological advancements and growing number of market players have increased the scope of Ebstein’s anomaly market.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3800448-ebstein-s-anomaly-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

Globally, the Ebstein’s anomaly market is expected to grow at a CAGR of around 9.0% during the forecast period. This report analyzes the global Ebstein’s anomaly market by treatment (medication, and surgical treatment) diagnosis (echocardiogram, electrocardiogram, chest x-ray, cardiac MRI, Holter monitor) end-users (hospitals & clinics, and specialty clinics); it also studies the top manufacturers in the market.

Market Segmentation
The global Ebstein’s Anomaly market is segmented on the basis of treatment, diagnosis and end users. On the basis of treatment, the global Ebstein’s anomaly market has been categorized into Medication and Surgical Treatment. When categorized on the basis of diagnosis, the market has been categorized into Echocardiogram, Electrocardiogram, Chest X-Ray, Cardiac MRI and Holter Monitor. Basis end-users, this market has been divided in to Hospitals & Clinics and Specialty Clinics.

Regional Analysis
North America Ebstein’s Anomaly market is rapidly growing in the American region. On a regional basis, the Americas is segmented into North America and South America. North America is segmented into the U.S. and Canada. According to CDC (Centre for Disease Control), it was estimated that about 1 million U.S. children and about 1.4 million U.S. adults were living with CHDs. Additionally, CHDs affect nearly 1% of―or about 40,000―births per year in the United States.
Europe is the second largest market and holds a healthy share in the global Ebstein’s Anomaly market. The European market is expected to steadily grow during the forecast period owing to the skilled professionals and availability of accessible and advanced treatment facilities.

Asia Pacific is expected to be the fastest growing market. India is the fastest growing region owing to the increasing population.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities.

Some of the key players in Ebstein’s Anomaly Market are Ebstein’s Anomaly market are Abbott Vascular, Boston Scientific Corporation, Cordis Corporation, Edwards Lifesciences, Ge Healthcare, Gore Medical, Medtronic, Inc., Numed, Inc., Siemens Healthcare, St. Jude Medical, and Toshiba Corporation among others.

Industry News
Increasing prevalence of chronic diseases such as diabetes is the major driver for the market growth. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drives the market. Additionally, wide research and development activities for the treatment of rare disease and increasing government funding also boosts the market growth globally.

Complete Report Details @ https://www.wiseguyreports.com/reports/3800448-ebstein-s-anomaly-market-research-report-forecast-to-2023

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Utility Management Systems Software Market Report 2019-2025 by Technology, Trends, Top Key Players and more

A new market study, titled “Global Utility Management Systems Software Market Report 2019 – Market Size, Share, Price, Trend and Forecast”, has been Published.

PUNE, MAHARASTRA, INDIA, August 30, 2019 /EINPresswire.com/ — Utility Management Systems Software Market

This report studies the global Utility Management Systems Software market, analyzes and researches the Utility Management Systems Software development status and forecast in Various geographical regions. Global Utility Management Systems Software Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Utility Management Systems Software industry.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Top Key Players Include
Cogsdale
Accela
SAP S/4HANA
Katapult Engineering
PenguinData Workforce Management
Qlik
For complete companies list, please ask for sample pages.

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4081600-global-utility-management-systems-software-market-report-2019

The information for each competitor includes:
Company Profile
Main Business Information
SWOT Analysis
Sales, Revenue, Price and Gross Margin
Market Share

For product type segment, this report listed main product type of Utility Management Systems Software market
Product Type I
Product Type II
Product Type III

For end use/application segment, this report focuses on the status and outlook for key applications. End users are also listed.
Application I
Application II
Application III

This report covers following regions:
North America
South America
Asia & Pacific
Europe
MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Reasons to Purchase this Report:
Analyzing the outlook of the market with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.

View Detailed Report at https://www.wiseguyreports.com/reports/4081600-global-utility-management-systems-software-market-report-2019

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Cloud Business Email Market Report 2019-2025 by Technology, Future Trends, Opportunities, Top Key Players & more

A new market study,titled “Global Cloud Business Email Market Report 2019- Market Size, Share, Price, Trend and Forecast”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, August 30, 2019 /EINPresswire.com/ — Cloud Business Email Market

Electronic mail (email or e-mail) is a method of exchanging messages ("mail") between people using electronic devices. Email first entered limited use in the 1960s and by the mid-1970s had taken the form now recognized as email. Email operates across computer networks, which today is primarily the Internet. Some early email systems required the author and the recipient to both be online at the same time, in common with instant messaging.

Global Cloud Business Email Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Cloud Business Email industry. There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Top Key Players Include
IBM Corporation
Google Inc.
Micro Focus International Plc
NEC Corporation
Amazon.Com
Hitachi
For complete companies list, please ask for sample pages.

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4081707-global-cloud-business-email-market-report-2019-market

The information for each competitor includes:
Company Profile
Main Business Information
SWOT Analysis
Sales, Revenue, Price and Gross Margin
Market Share

For product type segment, this report listed main product type of Cloud Business Email market
Windows
Linux
Unix
Mainframe
Others

For end use/application segment, this report focuses on the status and outlook for key applications. End users are also listed.
Application I
Application II
Application III

This report covers following regions:
North America
South America
Asia & Pacific
Europe
MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

Reasons to Purchase this Report:
Analyzing the outlook of the market with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.

View Detailed Report at https://www.wiseguyreports.com/reports/4081707-global-cloud-business-email-market-report-2019-market

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

The Roundup Options Help Center of Texas Encourages Those Diagnosed with NHL or CLL to Call The Steinberg Law Group

Glyphosate-based weed killers are carcinogenic.

Roundup is one of many glyphosate-based weed killers on the market.

Experience/Resources/Results

The Roundup Options Help Center of Texas Encourages Those Diagnosed with Non-Hodgkin’s Lymphoma to Call for Access to Attorneys at The Steinberg Law Group

Monsanto is making a product that's at least 10 times, maybe 100 times safer all across Europe.”

— Charles Benbrook, Agricultural Economist

HOUSTON, TEXAS, USA, August 29, 2019 /EINPresswire.com/ — The Roundup Options Help Center of Texas is dedicated to providing the best legal assistance to people stricken with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia from exposure to Roundup or other glyphosate-based weed killers. Anyone wishing to discuss their legal options should call (888) 891-2200 to speak directly with a member of The Steinberg Law Group.

The Roundup Options Help Center of Texas has endorsed The Steinberg Law Group because of their decades of experience in handling mass action and class action cases. With offices in New York, California and Texas, The Steinberg Law Group has a national footprint that helps them obtain the best possible financial compensation for clients.

Roundup is a glyphosate-based herbicide originally produced by Monsanto and introduced to the consumer market in 1974. Monsanto, which Bayer acquired in 2018, developed and patented the glyphosate molecule and retained exclusive rights to glyphosate in the US until its US patent expired in September 2000 (the patent expired earlier in other countries). As a result, today, many similar products use glyphosate as an active ingredient.

The World Health Organization’s International Agency for Research on Cancer identified glyphosate as a probable human carcinogen. Despite evidence that Monsanto and other producers of glyphosate-based herbicides knew of the probable cancer-causing effects of their products, consumers were not properly warned of the potential dangers. States with the highest risk of glyphosate exposure include Minnesota, North Dakota, Ohio, Indiana, Illinois, Michigan, Iowa and Ohio. On average, Non-Hodgkin’s Lymphoma takes up to 10 years to emerge so even if one's glyphosate exposure occurred outside of their home state, The Steinberg Law Group can still obtain the maximum financial compensation available.

If you or a loved one has been diagnosed with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia and used Roundup or other glyphosate-based herbicides after 1990, the Roundup Options Help Center of Texas encourages calling (888) 891-2200 or visiting roundupoptions.com for more information on how The Steinberg Law Group can help.

Monica Rivera
Roundup Options Help Center
+1 8888912200
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire